Loading organizations...
Loading organizations...
Provider of small molecule therapies to stimulate cancer immunity.
NeoPhore has raised $44.6M across 4 funding rounds.
NeoPhore has raised $44.6M in total across 4 funding rounds.
NeoPhore has raised $44.6M in total across 4 funding rounds.
NeoPhore's investors include 2Invest, 3B Future Health Fund, Astellas Venture Management, Claris Ventures, CPF, Stefano Buono, Neva SGR, Simon Fiduciaria, CRT Pioneer Fund, Pietro Puglisi, Heikki Lanckriet, Marianne Bjordal.
NeoPhore has raised $44.6M across 4 funding rounds. Most recently, it raised $12.2M Series B in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $12.2M Series B | 2Invest, 3B Future Health Fund, Astellas Venture Management, Claris Ventures, CPF, Stefano Buono, Neva SGR, Simon Fiduciaria | |
| Jan 19, 2023 | $7.4M Series B Extension | 2Invest, 3B Future Health Fund, Astellas Venture Management, Claris Ventures, CRT Pioneer Fund | |
| Mar 9, 2021 | $21.1M Series B | Pietro Puglisi | Heikki Lanckriet, Marianne Bjordal, Astellas Venture Management, CRT Pioneer Fund |
| Nov 16, 2017 | $4.0M Other Equity | Robert James |